• FAQs
  • Glossary
Close

FAQs

Why are some conditions more suitable for gene and cell therapies than others?
There is an approved treatment available for my condition - why can't I receive it?
How to look for approved medicines?
How are medicines developed and approved?

See all FAQs

Close

Glossary

Adeno-associated virus (AAV)
Adenovirus
Adult stem cells
Antibody
Antigen
Base editors
Cas9 nuclease
Chimeric Antigen Receptor (CAR)
Chromosome
Clinical trial

See full Glossary

ATMP Engage PPI Directory

The PPI Directory contains patient and public involvement (PPI) resources for developers of cell and gene therapies, including toolkits, guidelines, advice, templates and case studies.

PPI Directory

PPI Themes
Research Field
Organisation Type
Development Stage
Audience
Country
Content Type
    Showing 1 of 11 results.
    Page 3 of 3

    Patient and Public Involvement

    Toolkit of resources by NHS Accelerated Access Collaborative (AAC)
    Visit this Resource

    Research Field

    • General
    • Pharmaceutical

    Organisation Type

    • Funder
    • Healthcare

    Development Stage

    • Identifying/Prioritising Patient Need
    • Research and Clinical Development
    • Service Delivery

    Audience

    • Researchers/Developers
    • Public/Patients
    • Industry

    Country

    • UK

    Content Type

    • Resource
    Back to top